Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial
PaperCitations, authors & open-access status
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 182 citations, 2017 year and hybrid oa status.
182
Citations
2017
Year
hybrid
OA Status